|Ms. Caren L. Mason||CEO, Pres & Director||1.39M||N/A||1954|
|Ms. Deborah J. Andrews||Chief Financial Officer||616.49k||620.08k||1957|
|Dr. Keith Holliday||Chief Technology Officer||678.25k||N/A||1963|
|Mr. Samuel J. Gesten||Chief Legal Officer & Corp. Sec.||658.25k||N/A||1962|
|Mr. Hans-Martin Blickensdoerfer||Sr. VP of Commercial Operations, Direct Markets- Europe & China||626.39k||N/A||1965|
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Monrovia, California.
STAAR Surgical Company’s ISS Governance QualityScore as of October 4, 2019 is 3. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 6; Compensation: 5.